Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services symbols : Nvs save search
Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics
Published: 2023-10-13 (Crawled : 16:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 6.8K
|
Health Technology
|
| O: -1.86%
H: 0.0%
C: 0.0%
ALPMY | News | $9.47 -0.21% -1.11% 20K
|
Manufacturing
|
| O: -2.78%
H: 0.04%
C: -0.57%
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: -0.21%
H: 0.42%
C: -1.17%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.55%
H: 0.69%
C: -0.09%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 0.64%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: -0.59%
H: 0.62%
C: -0.56%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.93%
H: 0.26%
C: -1.25%
management growing
Autism Spectrum Disorder Therapeutics Market to Grow by USD 772.65 million from 2022 to 2027 | Increasing prevalence of ASD boosts the market growth - Technavio
Published: 2023-08-30 (Crawled : 01:00) - prnewswire.com
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: -27.59%
H: 0.0%
C: 0.0%
TVTX | $5.45 -5.05% -5.13% 940K
|
Health Technology
|
| O: 0.69%
H: 0.98%
C: -0.15%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.25%
H: 0.47%
C: -1.08%
JAZZ | $108.32 -1.23% -1.19% 400K
|
Health Technology
|
| O: 1.08%
H: 1.22%
C: 0.92%
therapeutics growth market
RNAi Drug Delivery Market worth $109.73 billion between 2022-2027- Exclusive report by Technavio
Published: 2023-07-27 (Crawled : 08:00) - prnewswire.com
RNAZ | $0.4399 -4.35% -1.75% 90K
|
Professional, Scientific, and T...
|
| O: 2.57%
H: 3.43%
C: 0.47%
TMO | News | $577.39 0.49% -0.38% 1.7M
|
Health Technology
|
| O: 0.17%
H: 0.35%
C: -2.67%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.7%
H: 0.12%
C: -0.76%
SLN | $22.27 -1.07% -0.81% 110K
|
Health Technology
|
| O: 2.61%
H: 0.27%
C: -2.18%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
BNTX | News | $88.09 -0.45% -0.35% 1.9K
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
BNTC | $6.72 -2.04% -1.63% 67K
|
Health Technology
|
| O: -8.92%
H: 9.49%
C: 0.59%
drug report market
Viral Vector Manufacturing Market worth $12.8 billion | MarketsandMarkets
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
LZAGF | $557.715 -0.19% -19.1% 0
|
Health Technology
|
| O: 3.47%
H: 0.0%
C: -2.56%
LZAGY | $57.27 -0.52% 0.02% 0
|
Professional, Scientific, and T...
|
| O: -0.59%
H: 0.02%
C: 0.02%
TMO | News | $577.39 0.49% -0.38% 1.7M
|
Health Technology
|
| O: 0.35%
H: 0.91%
C: 0.71%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -0.76%
DHR | $250.41 -1.07% -0.46% 2.3M
|
Health Technology
|
| O: 0.0%
H: 1.29%
C: 1.14%
CRL | News | $239.43 -0.29% 0.0% 1
|
Commercial Services
|
| O: 0.08%
H: 5.1%
C: 3.86%
BLUE | $0.9229 -4.91% -4.66% 14K
|
Health Technology
|
| O: 1.37%
H: 0.29%
C: -5.41%
market
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
Published: 2023-06-08 (Crawled : 13:20) - biospace.com/
DAWN S | $15.19 -8.71% -9.62% 1.5K
|
Professional, Scientific, and T...
|
| O: -0.69%
H: 0.0%
C: -7.55%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 1.26%
H: 1.08%
C: 0.91%
KZIA | $0.389 -1.52% 0.03% 380
|
Health Technology
|
| O: 1.57%
H: 3.07%
C: 1.53%
paxalisib therapeutics study
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA
Published: 2023-06-08 (Crawled : 11:00) - prnewswire.com
DAWN S | $15.19 -8.71% -9.62% 1.5K
|
Professional, Scientific, and T...
|
| O: -0.69%
H: 0.0%
C: -7.55%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 1.26%
H: 1.08%
C: 0.91%
KZIA | $0.389 -1.52% 0.03% 380
|
Health Technology
|
| O: 1.57%
H: 3.07%
C: 1.53%
paxalisib therapeutics study
Pulmonary arterial hypertension (PAH) drugs market size to grow by USD 2,080.07 million between 2022 and 2027; Growth driven by growing prevalence of PAH - Technavio
Published: 2023-04-18 (Crawled : 07:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0
|
Health Technology
|
| O: -6.76%
H: 3.18%
C: 1.34%
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: 2.33%
H: 0.7%
C: -0.88%
AVTE M | $21.2 -8.7% -9.17% 0
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 2.26%
C: 1.38%
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: 0.2%
H: 0.09%
C: -0.5%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.18%
H: 0.11%
C: -0.85%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: -0.64%
H: 0.23%
C: -1.0%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 2.35%
H: 0.62%
C: -0.45%
growing hypertension growth market
Liver Cancer Drugs Market size to grow at a CAGR of 14.67% from 2021 to 2026, Driven by the growing incidence of liver cancer - Technavio
Published: 2023-04-12 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: 5.41%
H: 0.0%
C: -2.14%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 3.57%
C: 3.57%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.75%
H: 0.5%
C: -0.05%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 1.96%
H: 0.71%
C: 0.22%
liver cancer growing market
TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
Published: 2023-03-08 (Crawled : 14:00) - biospace.com/
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 2.45%
H: 0.0%
C: 0.0%
TCRX | News 3 d | $7.38 1.65% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: -2.73%
H: 6.07%
C: 3.43%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.42%
year therapeutics financial results
Regenerative Medicine Market to be Worth $180.87 Billion by 2030: Grand View Research, Inc.
Published: 2023-02-14 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: 0.43%
H: 1.52%
C: -1.88%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
USRM | $0.0001 1300.0% 290K
|
Professional, Scientific, and T...
|
| O: 2.22%
H: 4.35%
C: 4.35%
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: 0.23%
H: 0.25%
C: -0.84%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.27%
H: 0.42%
C: -0.21%
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: 0.04%
H: 0.93%
C: -0.85%
NUVA | $39.75 -2.24% -2.29% 0
|
Health Technology
|
| O: -0.16%
H: 2.24%
C: 0.79%
MDXG | $6.43 -1.23% -1.09% 650K
|
Health Technology
|
| O: -1.3%
H: 2.85%
C: 2.19%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 0.3%
H: 0.94%
C: 0.6%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.39%
H: 0.12%
C: -0.69%
market
Liver cancer drugs market size to grow by USD 5.29 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
Published: 2023-02-09 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: 6.07%
H: 1.75%
C: 0.35%
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: -4.0%
H: 4.17%
C: 4.17%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.87%
H: 0.17%
C: -1.53%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 6.13%
H: 0.42%
C: -1.3%
liver cancer market
Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
EMMA | $0.1 8.58% 385.44% 0
|
Professional, Scientific, and T...
|
| O: 33.02%
H: 0.0%
C: -21.11%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -5.8%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.74%
H: 0.89%
C: 0.53%
DHR | $250.41 -1.07% -0.46% 2.3M
|
Health Technology
|
| O: -0.32%
H: 1.21%
C: 0.09%
ABT | News | $106.89 -0.65% -0.09% 4.2M
|
Health Technology
|
| O: -0.13%
H: 1.13%
C: 0.14%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M
|
Health Technology
|
| O: -1.1%
H: 1.66%
C: -0.28%
ALNY | $143.8 -1.55% -1.58% 400K
|
Health Technology
|
| O: 0.22%
H: 2.19%
C: -5.13%
global report market
Sickle Cell Disease Treatment Market to Garner USD 1.6 Billion by 2031: Allied Market Research
Published: 2022-11-10 (Crawled : 01:00) - prnewswire.com
EMMA | $0.1 8.58% 385.44% 0
|
Professional, Scientific, and T...
|
| O: -18.92%
H: 15.0%
C: 15.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
treatment research disease market
Global Small-Molecule APIs Market to Reach $38.54 Billion by 2027
Published: 2022-08-19 (Crawled : 12:00) - prnewswire.com
LZAGF | $557.715 -0.19% -19.1% 0
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: -1.85%
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
LZAGY | $57.27 -0.52% 0.02% 0
|
Professional, Scientific, and T...
|
| O: -0.73%
H: 0.29%
C: -1.26%
TEVA | $13.01 -0.31% 7.1M
|
Health Technology
|
| O: 0.68%
H: 0.77%
C: -0.38%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.44%
H: 0.63%
C: 0.55%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: 0.09%
H: 0.61%
C: -0.64%
ALB | News | $115.27 0.93% 0.46% 1.8M
|
Process Industries
|
| O: -1.28%
H: 0.03%
C: -2.14%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.35%
H: 1.11%
C: 0.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
global market
LAMEA Peptide Therapeutics Market Report 2022: Annual Growth of 12.5% Expected Through 2028
Published: 2022-08-05 (Crawled : 15:20) - prnewswire.com
LZAGF | $557.715 -0.19% -19.1% 0
|
Health Technology
|
| O: -4.5%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 -3.77% -14.18% 0
|
Health Technology
|
| O: -6.04%
H: 2.59%
C: 2.59%
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: -4.45%
LZAGY | $57.27 -0.52% 0.02% 0
|
Professional, Scientific, and T...
|
| O: -3.78%
H: 0.57%
C: 0.36%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.65%
H: 0.29%
C: 0.0%
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.44%
H: 0.66%
C: -0.75%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.16%
H: 0.71%
C: 0.56%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: -1.26%
H: 1.36%
C: 1.2%
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: -1.08%
H: 0.94%
C: -0.38%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: -0.63%
H: 0.63%
C: 0.24%
report expected therapeutics growth market
U.S. Small-Molecule APIs Market to Reach $7.84 Billion by 2027
Published: 2022-08-03 (Crawled : 11:00) - prnewswire.com
LZAGF | $557.715 -0.19% -19.1% 0
|
Health Technology
|
| O: -3.53%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 -3.77% -14.18% 0
|
Health Technology
|
| O: -1.8%
H: 0.2%
C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: -2.6%
H: 0.0%
C: -0.76%
LZAGY | $57.27 -0.52% 0.02% 0
|
Professional, Scientific, and T...
|
| O: 0.55%
H: 0.48%
C: 0.36%
TEVA | $13.01 -0.31% 7.1M
|
Health Technology
|
| O: 0.71%
H: 1.52%
C: 0.71%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.11%
H: 0.31%
C: -0.34%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: -0.29%
H: 0.24%
C: -0.58%
ALB | News | $115.27 0.93% 0.46% 1.8M
|
Process Industries
|
| O: 0.87%
H: 0.0%
C: -2.63%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.17%
H: 0.12%
C: -1.29%
market
INVESTOR DEADLINE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLN
Published: 2022-07-16 (Crawled : 08:20) - prnewswire.com
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
| Email alert
Add to watchlist
MOLN | $3.61 -6.23% -3.54% 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
| Email alert
Add to watchlist
molecular
Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published: 2022-06-21 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: 6.34%
H: 0.0%
C: -4.65%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 4.65%
H: 0.0%
C: -4.51%
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 46.85%
H: 0.0%
C: -30.95%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: 0.0%
research liver cancer market
Liver Cancer Drugs Market - 42% of Growth to Originate from North America | Evolving Opportunities with AstraZeneca Plc & Bayer AG| 17000+ Technavio Reports
Published: 2022-03-30 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: -5.22%
H: 6.2%
C: 1.91%
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.0%
C: -15.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.58%
H: 0.56%
C: -0.07%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 0.42%
H: 1.49%
C: 1.34%
america liver cancer growth market
Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
Published: 2022-03-15 (Crawled : 21:00) - globenewswire.com
MOLN | $3.61 -6.23% -3.54% 0
|
Professional, Scientific, and T...
|
| O: -0.2%
H: 0.24%
C: -0.46%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
als report molecular
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
MTH | $154.69 -2.21% 7.56% 64
|
Consumer Durables
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
IHT P | $1.3712 0.82% 6.48% 0
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.